U.S. Online Retail and Ecommerce Stock News

NasdaqGS:WGS
NasdaqGS:WGSHealthcare

3 Stocks Including FinWise Bancorp Estimated To Be Priced Below Intrinsic Value

As the United States stock market experiences a period of gains with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly increases, investors are keenly observing opportunities that may be priced below their intrinsic value. In such an environment, identifying stocks that appear undervalued can be crucial for those looking to capitalize on potential market inefficiencies and enhance portfolio performance.
NasdaqCM:CRGO
NasdaqCM:CRGOLogistics

3 Promising Penny Stocks With Market Caps Under $200M

The United States stock market has recently closed on a high note, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly gains. For investors willing to explore beyond the well-known giants, penny stocks—often representing smaller or newer companies—continue to offer intriguing opportunities. Despite being an older term, these stocks can present significant growth potential when backed by strong financials and sound fundamentals.
NasdaqCM:PKBK
NasdaqCM:PKBKBanks

3 Undiscovered Gems In The US Market With Strong Potential

As the U.S. stock market continues to experience robust growth, with major indices like the Nasdaq and S&P 500 posting impressive weekly and monthly gains, investors are increasingly on the lookout for opportunities beyond the well-trodden paths of large-cap giants. In this dynamic landscape, identifying promising small-cap stocks that demonstrate resilience and growth potential can be a rewarding strategy for those seeking to diversify their portfolios amidst broader market optimism.
NasdaqCM:VTGN
NasdaqCM:VTGNBiotechs

Assessing Vistagen Therapeutics’s (VTGN) Valuation After Board Addition of Pharma Executive Paul Edick

Vistagen Therapeutics (VTGN) just named Paul Edick to its Board of Directors, bringing an executive with decades of pharmaceutical leadership to the team. Edick will join the Audit and Compensation Committees. See our latest analysis for Vistagen Therapeutics. Momentum has picked up for Vistagen Therapeutics lately, with the share price climbing nearly 35% over the past three months and putting its year-to-date share price return just under 19%. While the stock’s one-year total shareholder...
NasdaqCM:OSPN
NasdaqCM:OSPNSoftware

Will OneSpan’s (OSPN) Shift to Software Unlock Growth Amid Lowered Guidance and Buybacks?

On October 30, 2025, OneSpan reported third quarter earnings, with revenue rising to US$57.06 million but net income falling to US$6.51 million, alongside a reduction in full-year 2025 guidance and the completion of a share buyback and dividend affirmation. An interesting development is the company's ongoing shift toward software and services, highlighted by recent acquisitions and investments intended to accelerate future growth despite current hardware headwinds. We'll explore how...
NasdaqCM:TALK
NasdaqCM:TALKHealthcare

Talkspace (TALK): Assessing Valuation Following Record Q3 Revenue Growth and Profitability Jump

Talkspace (TALK) caught investors’ attention after reporting standout third-quarter results, highlighted by record revenue growth and a significant increase in profitability. The company’s payer business, in particular, was a strong driver this quarter. See our latest analysis for Talkspace. The upbeat earnings have fueled impressive price momentum, with Talkspace’s shares rallying 42% over the past three months and gaining 17% in just the last month alone. Despite recent volatility in the...
NYSE:JBL
NYSE:JBLElectronic

November 2025's Stocks That May Be Trading Below Estimated Value

As of the end of October 2025, U.S. stock markets have shown resilience, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid gains for both the week and month. In this environment of growth and recovery, identifying stocks that may be trading below their estimated value can present opportunities for investors seeking to capitalize on potential market inefficiencies.
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Astera Labs And 2 Other Growth Companies With Significant Insider Ownership

As the U.S. stock market continues to show strength with major indexes posting weekly and monthly gains, investors are increasingly interested in growth companies that demonstrate robust performance and resilience. In this favorable environment, stocks with significant insider ownership can be particularly appealing, as they often indicate a strong alignment between company leaders and shareholders' interests.
NasdaqGM:MNOV
NasdaqGM:MNOVBiotechs

3 Penny Stocks With Market Caps Over $80M To Consider

As the United States stock market continues to post gains, boosted by strong performances from tech giants like Amazon, investors are exploring diverse opportunities across various sectors. Penny stocks, while often considered a relic of past trading days, still hold relevance as they offer potential growth at lower price points. When backed by solid financials and robust fundamentals, these smaller or newer companies can defy expectations and present significant returns.
NasdaqGS:COLB
NasdaqGS:COLBBanks

Top Dividend Stocks To Consider In November 2025

As October 2025 comes to a close, the U.S. stock market has shown resilience, with major indices like the Nasdaq, S&P 500, and Dow Jones Industrial Average posting solid weekly and monthly gains. In this environment of robust market performance, dividend stocks continue to attract attention for their potential to provide steady income streams alongside capital appreciation. A good dividend stock in such conditions typically combines a reliable payout history with strong fundamentals that can...